VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HIT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HITHealth In Tech, Inc.
$1.04$56M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHITQuarterly Financials

Health In Tech, Inc. (HIT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Health In Tech, Inc. (HIT) quarterly income statement — complete revenue, gross profit & net income history

HIT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Sales/Revenue8.77M7.51M8.49M9.31M8.01M4.9M4.46M5M5.12M5.22M
Revenue Growth %9.44%53.09%90.41%86.18%56.39%-5.98%----
Cost of Goods Sold4.26M3.38M3.35M3M2.66M1.11M979.63K974.73K989.91K951.97K
COGS % of Revenue48.59%45.01%39.41%32.25%33.18%22.57%21.97%19.48%19.32%18.25%
Gross Profit4.51M4.13M5.14M6.31M5.36M3.8M3.48M4.03M4.14M4.26M
Gross Margin %51.41%54.99%60.59%67.75%66.82%77.43%78.03%80.52%80.68%81.75%
Gross Profit Growth %-15.8%8.72%47.84%56.66%29.51%-10.95%----
Operating Expenses6.67M4.3M4.65M5.58M4.87M4.11M3.04M3.49M3.8M2.81M
OpEx % of Revenue76.01%57.26%54.77%59.96%60.82%83.88%68.19%69.82%74.2%53.85%
Selling, General & Admin5.75M4.09M4.41M5M4.34M3.48M2.32M2.79M3.04M2.14M
SG&A % of Revenue65.52%54.42%52%53.71%54.11%70.96%52.08%55.8%59.36%40.94%
Research & Development920.39K213.11K235.82K582.61K537.72K633.65K718.42K701.63K760.2K673.44K
R&D % of Revenue10.49%2.84%2.78%6.26%6.71%12.92%16.11%14.03%14.83%12.91%
Other Operating Expenses0000000000
Operating Income-2.16M-170.81K493.52K725.07K480.66K-316.34K438.88K534.94K332.42K1.46M
Operating Margin %-24.6%-2.27%5.81%7.78%6%-6.45%9.84%10.69%6.49%27.9%
Operating Income Growth %-549%46%12.45%35.54%44.59%-121.74%----
EBITDA-1.75M239.82K711.5K861.05K616.64K-180.35K574.47K669.72K467.21K1.59M
EBITDA Margin %-20%3.19%8.38%9.24%7.69%-3.68%12.88%13.39%9.12%30.42%
EBITDA Growth %-384.56%232.97%23.85%28.57%31.98%-111.37%----
D&A (Non-Cash Add-back)403.47K410.63K217.98K135.98K135.98K135.98K135.58K134.79K134.79K131.43K
EBIT-2.16M-443.74K600.22K833.27K684.42K-110.75K571.74K566.27K356.73K1.48M
Net Interest Income67.47K104.66K111.7K108.2K85.37K28.77K-126.54K-133.66K-140.69K25.03K
Interest Income67.47K104.66K111.7K108.2K85.37K28.77K38.46K31.34K24.31K26.13K
Interest Expense000000165K165K165K1.1K
Other Income/Expense89.81K-272.93K106.7K108.2K203.76K205.59K-32.14K-133.66K-140.69K25.03K
Pretax Income-2.07M-443.74K600.22K833.27K684.42K-110.75K406.74K401.27K191.73K1.48M
Pretax Margin %-23.58%-5.91%7.07%8.95%8.54%-2.26%9.12%8.02%3.74%28.38%
Income Tax-480.07K-141.18K148.05K202.64K185.83K33.4K30.65K63.27K91.2K478.11K
Effective Tax Rate %23.21%31.82%24.67%24.32%27.15%-30.16%7.54%15.77%47.56%32.3%
Net Income-1.59M-302.56K452.18K630.63K498.59K-144.15K376.09K338.01K100.54K1M
Net Margin %-18.11%-4.03%5.33%6.77%6.22%-2.94%8.43%6.76%1.96%19.21%
Net Income Growth %-418.55%-109.89%20.23%86.57%395.93%-114.38%----
Net Income (Continuing)-1.59M-302.56K452.18K630.63K498.59K-144.15K376.09K338.01K100.54K1M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)-0.03-0.010.010.010.01-0.000.010.010.000.02
EPS Growth %------114.21%----
EPS (Basic)-0.03-0.010.010.010.01-0.000.010.010.000.02
Diluted Shares Outstanding57.35M58.64M58.77M55.63M57M54.07M54.07M54.07M54.07M54.07M
Basic Shares Outstanding57.35M55.84M56.43M55.38M54.62M54.07M54.07M54.07M54.07M54.07M
Dividend Payout Ratio----------